Pentobarbital 2,500 MG/50 ML 50ML
Ended Awarded
- Contract number
- SPE2DB25FE4E9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,260
Award facts
- Contract value 100% obligated
- $42,260.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Pentobarbital 2,500 mg/50 ml in 50 ml units, with a ceiling value of $42,260. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program (SPE2DX)—which is valued at $999,999,999 and extends through December 2026, enabling comprehensive pharmaceutical support to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds significant federal contract portfolios with the Defense Logistics Agency, supplying an extensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The DLA Troop Support Medical contract vehicle represents a flexible mechanism through which AmerisourceBergen can fulfill diverse pharmaceutical supply needs for military healthcare programs worldwide, with the agency planning future multi-award contracts under Pharmaceutical Prime Vendor Global Program Generation V to expand regional coverage.
Quick answers
Who was awarded contract SPE2DB25FE4E9?
SPE2DB25FE4E9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FE4E9 worth?
The government has obligated $42,260 on SPE2DB25FE4E9.
Is contract SPE2DB25FE4E9 an order under another contract?
Yes. SPE2DB25FE4E9 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE4E9 competed?
The extent of competition for SPE2DB25FE4E9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award